Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 28;78(11):2077-2082.
doi: 10.1093/gerona/glad132.

Associations Between Circulating Levels of Myostatin and Plasma β-Amyloid 42/40 in a Biracial Cohort of Older Adults

Affiliations

Associations Between Circulating Levels of Myostatin and Plasma β-Amyloid 42/40 in a Biracial Cohort of Older Adults

Brendan L McNeish et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: Myostatin, a cytokine produced by skeletal muscle, may influence Alzheimer's disease (AD) pathogenesis, but sparse evidence exists in humans. We assessed the association between circulating levels of myostatin at Year 1 and plasma levels of β-amyloid 42/40 at Year 2, a marker of AD pathology, in a biracial cohort of older adults.

Methods: We studied 403 community-dwelling older adults enrolled in the Health, Aging and Body Composition Study from Memphis, Tennessee, and Pittsburgh, PA. Mean age was 73.8 ± 3 years; 54% were female; and 52% were Black. Serum myostatin levels were measured at Year 1, plasma β-amyloid 42/40 levels in Year 2 (higher ratio indicating lower amyloid load). Multivariable linear regression analyses tested the association of serum myostatin with plasma levels of β-amyloid 42/40 adjusted for computed-tomography-derived thigh muscle cross-sectional area, demographics, APOe4 allele, and risk factors for dementia. We tested for 2-way.interactions between myostatin and race or sex; results were stratified by race and sex.

Results: In multivariable models, myostatin was positively associated with plasma levels of β-amyloid 42/40 (standardized regression coefficient: 0.145, p = .004). Results were significant for white men and women (0.279, p = .009, and 0.221, p = .035, respectively) but not for Black men or women; interactions by race and gender were not statistically significant.

Conclusions: Higher serum myostatin was associated with lower amyloid burden, independently of APOe4 alleles, muscle area and other established risk factors for dementia. The role of myostatin in AD pathogenesis and the influence of race should be further investigated.

Keywords: Alzheimer’s; Biomarkers; Cognitive aging; Muscle.

PubMed Disclaimer

Conflict of interest statement

A.N., B.L.M., X.Z., B.G., I.M., K.Y., and C.R. report no competing interests. P.C. receives consulting fees from BioAge.

Figures

Figure 1.
Figure 1.
Results of multivariable linear regression models of myostatin as a determinant of plasma β-amyloid 42/40, in the total cohort and stratified by race and gender. All models are adjusted for age, APOE4, muscle area, education, physical activity, and hypertension. Models in the full cohort are also adjusted for race and gender. *p < .05.

Similar articles

Cited by

References

    1. Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA.. Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement J Alzheimers Assoc. 2021;17(12):1966–1975. doi:10.1002/alz.12362 - DOI - PMC - PubMed
    1. Liang CS, Li DJ, Yang FC, et al. . Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias: a systematic review and meta-analysis. Lancet Healthy Longev. 2021;2(8):e479–e488 doi:10.1016/S2666-7568(21)00140-9 - DOI - PubMed
    1. Walker MD, Salek SS, Bayer AJ.. A review of quality of life in Alzheimer’s disease. PharmacoEconomics. 1998;14(5):499–530 doi:10.2165/00019053-199814050-00004 - DOI - PubMed
    1. Zhao Y, Kuo TC, Weir S, Kramer MS, Ash AS.. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer’s. BMC Health Serv Res. 2008;8(1):108. doi:10.1186/1472-6963-8-108 - DOI - PMC - PubMed
    1. Power MC, Bennett EE, Turner RW, et al. . Trends in relative incidence and prevalence of dementia across non-Hispanic black and white individuals in the United States, 2000–2016. JAMA Neurol. 2021;78(3):275–284 doi:10.1001/jamaneurol.2020.4471 - DOI - PMC - PubMed

Publication types